Solarvest BioEnergy Inc V.SVS.H

Solarvest BioEnergy Inc. is a Canada-based algae biologics company. It is focused on three divisions: organic Omega-3 docosahexaenoic acid (DHA), protein expression and bio-hydrogen. Its flexible production platform is capable of producing numerous product lines for different usage. It has developed and patented Omega-3 that is ocean-based (DHA and Eicosapentaenoic Acid (EPA)) and organic. The products are produced without chemicals, solvents and/or heavy processing that degrade the nutritional benefits. It offers a plant-based and sustainable product while avoiding ocean-based toxins/pollutants or residual processing solvents. Its project focuses on cannabinoids, which implements a research and development program to produce cannabidiol (CBD), cannabigerol (CBG) and tetrahydrocannabinol (THC). It has also produced Bone Morphogenetic Protein (BMP) in micro algae. Its solar harvesting technology uses the sun, algae, and water to produce clean fuel with no carbon dioxide (CO2) footprint.

TSXV:SVS.H - Post by User

Solarvest BioEnergy Inc

<< Previous

Bullboard Posts

Next >>

Post by lscfaon Apr 27, 2021 11:21am

195 Views

Post# 33074313

Patents granted

Solarvest Bioenergy Inc. Granted Patents in India And Australia

Vancouver, B.C. - TheNewswire - April 27, 2021 – Solarvest BioEnergy Inc. (“Solarvest”, or the “Company”) (TSXV:SVS) (“Solarvest” or the “Company”), announces that it has been granted patents in Australia and India. The intellectual property protection concentrates on the production of algal biomass, algal cell cultures, lipid compounds, and compositions thereof, including fatty acids, carotenoids and fat soluble vitamins. These patents add additional strength to the Company’s existing patent portfolio as it commercializes its line of organic Omega-3 products.

After its initial product launch and further industry discussions, the Company has focused on supplying unique “clean label” products to satisfy the demand for premium plant-based, organic Omega-3 health products. In addition, the Company’s wholly owned subsidiary Eversea has accelerated efforts to offer organic marketing companies and organic oriented retailers with house branded products (often termed “white label”) based on our unique bioavailable Omega-3 ingredient. Channel marketing feedback indicates that there is extensive market demand for the product’s unique characteristics, particularly among consumers focused on organic and vegan diets. The Company’s patented Omega-3 active ingredient has obtained FDA NDI (New Dietary Ingredient) certification, and is USDA and EU Organic Certified.

Further to marketing of Organic Omega-3 in the United States, the team has received substantial interest due to the timely introduction of a premium ingredient when the reality of chemical and heavy metal contamination in baby food has been brought to light. https://oversight.house.gov/sites/democrats.oversight.house.gov/files/2021-02-04%20ECP%20Baby%20Food%20Staff%20Report.pdf The versatility of the patented ingredient has enabled the Company to demonstrate various Organic Omega-3 products that can be integrated into existing marketing channels. Organic marketers fully recognize the value of chemical free production as a competitive advantage. Moreover, in terms of intellectual property protection, the IP has been described as a rare commodity in a growing market segment.